Cargando…
Urine 2-Hydroxyglutarate in Glioma
This letter compares the results of two studies on the oncometabolite 2-hydroxyglutarate in patients with isocitrate dehydrogenase (IDH) mutant and IDH wild-type glioma.
Autores principales: | Lombardi, Giuseppe, Della Puppa, Alessandro, Zagonel, Vittorina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978559/ https://www.ncbi.nlm.nih.gov/pubmed/27507897 http://dx.doi.org/10.1634/theoncologist.2016-0123 |
Ejemplares similares
-
Gliomas
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
An Overview of Fotemustine in High-Grade Gliomas: From Single Agent to Association with Bevacizumab
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
The Combination of Carmustine Wafers and Fotemustine in Recurrent Glioblastoma Patients: A Monoinstitutional Experience
por: Lombardi, Giuseppe, et al.
Publicado: (2014) -
Caring for Patients with Advanced Stage Cancer at the Time of COVID‐19
por: Brunello, Antonella, et al.
Publicado: (2020) -
L-2-Hydroxyglutaric Aciduria: An Ever-Expanding Phenotypic Spectrum
por: Kamath, Sneha Dayanand, et al.
Publicado: (2023)